Cart
sales@molnova.com
Bivatuzumab
CAS No. 214559-60-1
Bivatuzumab( —— )
Catalog No. M36909 CAS No. 214559-60-1
Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 613 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1454 | Get Quote |
|
| 50MG | 1841 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBivatuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionBivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
-
DescriptionBivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells.
-
In VitroBivatuzumab (10 μg/mL) stains CD44v6 in STS cells.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number214559-60-1
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Leuci V,et al. CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. Oncoimmunology. 2018 Feb 15;7(5):e1423167. ?
molnova catalog
related products
-
Pimecrolimus
Pimecrolimus, like all ascomycins, is an immunophilin ligand, which binds specifically to the cytosolic receptor, immunophilin macrophilin-12.
-
lithospermic acid
lithospermic acid is a potent anti-HIV agent and shows anti-gonadotrophic and anti-thyroidal effects.
-
Tetrahydropapaverine...
Tetrahydropapaverine, an analogue of salsolinol and tetrahydropapaveroline, has neurotoxicity on dopamine neurons.
